Warrants

3 Months Ended

Mar. 31, 2020

Warrants [Abstract]

WARRANTS

NOTE 6 – WARRANTS

In connection with the issuance of the convertible note (the "Note") with L2 Capital, LLC ("L2") and funding of the initial tranche of $50,000 on the Note, the Company also issued a common stock purchase warrant to purchase up to 381,905 shares of the Company's common stock pursuant to the terms therein as a commitment fee. At the time that each subsequent tranche under the Note is funded by L2 in cash, then on such funding date, the warrant shares shall immediately and automatically be increased by the quotient of 100% of the face value of the respective tranche and 110% of the VWAP of the common stock on the Trading Day (as defined in the Note) immediately prior to the funding date of the respective tranche. As of December 31, 2018, the Company had received multiple tranches for which it issued warrants to purchase shares of the Company's common stock.

These warrants have a variable exercise price per the above and expire in five years. The aggregate fair value of the warrants, which was allocated against the debt proceeds totaled $280,438 based on the Black Scholes Merton pricing model using the following estimates: exercise price ranging from $0.001 – 0.0071, 2.80% – 2.94% risk free rate, 252.42 – 258.24% volatility and expected life of the warrants of 5 years. The fair value was credited to additional paid in capital and debited to debt discount to be amortized over the term of the loan.

Range of Exercise Prices	Number Outstanding 3/31/2020		Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
$0.001 – 0.0071		22,669,092	3.69 years	$	0.0011